skip to main content
Idioma:
Refinado por: Nome da Publicação: Clinical Cancer Research remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Choueiri, Toni K ; Fishman, Mayer N ; Escudier, Bernard ; McDermott, David F ; Drake, Charles G ; Kluger, Harriet ; Stadler, Walter M ; Perez-Gracia, Jose Luis ; McNeel, Douglas G ; Curti, Brendan ; Harrison, Michael R ; Plimack, Elizabeth R ; Appleman, Leonard ; Fong, Lawrence ; Albiges, Laurence ; Cohen, Lewis ; Young, Tina C ; Chasalow, Scott D ; Ross-Macdonald, Petra ; Srivastava, Shivani ; Jure-Kunkel, Maria ; Kurland, John F ; Simon, Jason S ; Sznol, Mario

Clinical cancer research, 2016-11, Vol.22 (22), p.5461-5471 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

Pignon, Jean-Christophe ; Jegede, Opeyemi ; Shukla, Sachet A ; Braun, David A ; Horak, Christine E ; Wind-Rotolo, Megan ; Ishii, Yuko ; Catalano, Paul J ; Grosha, Jonian ; Flaifel, Abdallah ; Novak, Jesse S ; Mahoney, Kathleen M ; Freeman, Gordon J ; Sharpe, Arlene H ; Hodi, F Stephen ; Motzer, Robert J ; Choueiri, Toni K ; Wu, Catherine J ; Atkins, Michael B ; McDermott, David F ; Signoretti, Sabina

Clinical cancer research, 2019-04, Vol.25 (7), p.2174-2184 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study

Atkins, Michael B ; Hodi, F Stephen ; Thompson, John A ; McDermott, David F ; Hwu, Wen-Jen ; Lawrence, Donald P ; Dawson, Nancy A ; Wong, Deborah J ; Bhatia, Shailender ; James, Marihella ; Jain, Lokesh ; Robey, Seth ; Shu, Xinxin ; Homet Moreno, Blanca ; Perini, Rodolfo F ; Choueiri, Toni K ; Ribas, Antoni

Clinical cancer research, 2018-04, Vol.24 (8), p.1805-1815 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
4
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

Tannir, Nizar M ; Signoretti, Sabina ; Choueiri, Toni K ; McDermott, David F ; Motzer, Robert J ; Flaifel, Abdallah ; Pignon, Jean-Christophe ; Ficial, Miriam ; Frontera, Osvaldo Arén ; George, Saby ; Powles, Thomas ; Donskov, Frede ; Harrison, Michael R ; Barthélémy, Philippe ; Tykodi, Scott S ; Kocsis, Judit ; Ravaud, Alain ; Rodriguez-Cid, Jeronimo R ; Pal, Sumanta K ; Murad, Andre M ; Ishii, Yuko ; Saggi, Shruti Shally ; McHenry, M Brent ; Rini, Brian I

Clinical cancer research, 2021-01, Vol.27 (1), p.78-86 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma

Ficial, Miriam ; Jegede, Opeyemi A ; Sant'Angelo, Miriam ; Hou, Yue ; Flaifel, Abdallah ; Pignon, Jean-Christophe ; Braun, David A ; Wind-Rotolo, Megan ; Sticco-Ivins, Maura A ; Catalano, Paul J ; Freeman, Gordon J ; Sharpe, Arlene H ; Hodi, F Stephen ; Motzer, Robert J ; Wu, Catherine J ; Atkins, Michael B ; McDermott, David F ; Shukla, Sachet A ; Choueiri, Toni K ; Signoretti, Sabina

Clinical cancer research, 2021-03, Vol.27 (5), p.1371-1380 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

CDKN2A Alterations and Response to Immunotherapy in Solid Tumors

Adib, Elio ; Nassar, Amin H ; Akl, Elie W ; Abou Alaiwi, Sarah ; Nuzzo, Pier Vitale ; Mouhieddine, Tarek H ; Sonpavde, Guru ; Haddad, Robert I ; Mouw, Kent W ; Giannakis, Marios ; Hodi, F Stephen ; Shukla, Sachet A ; Gusev, Alexander ; Braun, David A ; Choueiri, Toni K ; Kwiatkowski, David J

Clinical cancer research, 2021-07, Vol.27 (14), p.4025-4035 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

Kwiatkowski, David J ; Choueiri, Toni K ; Fay, André P ; Rini, Brian I ; Thorner, Aaron R ; de Velasco, Guillermo ; Tyburczy, Magdalena E ; Hamieh, Lana ; Albiges, Laurence ; Agarwal, Neeraj ; Ho, Thai H ; Song, Jiaxi ; Pignon, Jean-Christophe ; Barrios, Pablo M ; Michaelson, M Dror ; Van Allen, Eliezer ; Krajewski, Katherine M ; Porta, Camillo ; Pal, Sumanta ; Bellmunt, Joaquim ; McDermott, David F ; Heng, Daniel Y C ; Gray, Kathryn P ; Signoretti, Sabina

Clinical cancer research, 2016-05, Vol.22 (10), p.2445-2452 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Regan, Meredith M ; Jegede, Opeyemi A ; Mantia, Charlene M ; Powles, Thomas ; Werner, Lillian ; Motzer, Robert J ; Tannir, Nizar M ; Lee, Chung-Han ; Tomita, Yoshihiko ; Voss, Martin H ; Plimack, Elizabeth R ; Choueiri, Toni K ; Rini, Brian I ; Hammers, Hans J ; Escudier, Bernard ; Albiges, Laurence ; Huo, Stephen ; Del Tejo, Viviana ; Stwalley, Brian ; Atkins, Michael B ; McDermott, David F

Clinical cancer research, 2021-12, Vol.27 (24), p.6687-6695 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials

Bellmunt, Joaquim ; de Wit, Ronald ; Fradet, Yves ; Climent, Miguel A ; Petrylak, Daniel P ; Lee, Jae-Lyun ; Fong, Lawrence ; Necchi, Andrea ; Sternberg, Cora N ; O'Donnell, Peter H ; Powles, Thomas ; Plimack, Elizabeth R ; Bajorin, Dean F ; Balar, Arjun V ; Castellano, Daniel ; Choueiri, Toni K ; Culine, Stephane ; Gerritsen, Winald ; Gurney, Howard ; Quinn, David I ; Vuky, Jacqueline ; Vogelzang, Nicholas J ; Cristescu, Razvan ; Lunceford, Jared ; Saadatpour, Assieh ; Loboda, Andrey ; Ma, Junshui ; Rajasagi, Mohini ; Godwin, James Luke ; Homet Moreno, Blanca ; Grivas, Petros

Clinical cancer research, 2022-05, Vol.28 (10), p.2050-2060 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Martini, Jean-François ; Plimack, Elizabeth R ; Choueiri, Toni K ; McDermott, David F ; Puzanov, Igor ; Fishman, Mayer N ; Cho, Daniel C ; Vaishampayan, Ulka ; Rosbrook, Bradley ; Fernandez, Kathrine C ; Tarazi, Jamal C ; George, Saby ; Atkins, Michael B

Clinical cancer research, 2020-11, Vol.26 (21), p.5598-5608 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.